Display options
Share it on

Mol Aspects Med. 2020 Aug 29;100893. doi: 10.1016/j.mam.2020.100893. Epub 2020 Aug 29.

WITHDRAWN: The Atlas of Inflammation Resolution (AIR).

Molecular aspects of medicine

Charles N Serhan, Shailendra K Gupta, Mauro Perretti, Catherine Godson, Eoin Brennan, Yongsheng Li, Oliver Soehnlein, Takao Shimizu, Oliver Werz, Valerio Chiurchiù, Angelo Azzi, Marc Dubourdeau, Suchi Smita Gupta, Patrick Schopohl, Matti Hoch, Dragana Gjorgevikj, Faiz M Khan, David Brauer, Anurag Tripathi, Konstantin Cesnulevicius, David Lescheid, Myron Schultz, Eva Särndahl, Dirk Repsilber, Robert Kruse, Angelo Sala, Jesper Z Haeggström, Bruce D Levy, János G Filep, Olaf Wolkenhauer

Affiliations

  1. Center for Experimental Therapeutics and Reperfusion Injury, Department of Anesthesiology, Perioperative and Pain Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, 02115, USA.
  2. Department of Systems Biology and Bioinformatics, University of Rostock, 18051, Rostock, Germany.
  3. The William Harvey Research Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, Charterhouse Square, London, EC1M 6BQ, UK.
  4. Diabetes Complications Research Centre, Conway Institute & School of Medicine, University College Dublin, Belfield, Dublin 4, Ireland.
  5. Department of Medical Oncology, Chongqing University Cancer Hospital, Chongqing, 400030, China.
  6. Department of Physiology and Pharmacology (FyFA), Karolinska Institutet, 17177, Stockholm, Sweden; German Center for Cardiovascular Research (DZHK), München, Germany; Institute for Cardiovascular Prevention (IPEK), Ludwig Maximilian University, 80336, München, Germany.
  7. Department of Lipidomics, Graduate School of Medicine, The University of Tokyo, 113-0033, Tokyo, Japan; National Center for Global Health and Medicine, 1-21-1 Toyama, Shinjuku-ku, Tokyo, Japan.
  8. Department of Pharmaceutical/Medicinal Chemistry, Institute of Pharmacy, Friedrich Schiller University Jena, 07743, Jena, Germany.
  9. Institute of Translational Pharmacology, National Research Council, 00133, Rome, Italy; Laboratory of Resolution of Neuroinflammation, IRCCS Santa Lucia Foundation, 00143, Rome, Italy.
  10. School of Graduate Biomedical Pharmacology and Drug Development Program at Tufts University, Boston, MA, 02111, USA.
  11. Ambiotis, Canal Biotech 2 - 3 Rue des Satellites, 31400, Toulouse, France.
  12. CSIR - Indian Institute of Toxicology Research, 226001, Lucknow, India.
  13. Department of Medical Affairs & Research, Heel GmbH, 76532, Baden-Baden, Germany.
  14. IRiSC - Inflammatory Response and Infection Susceptibility Centre, Faculty of Medicine and Health, Örebro University, SE-701 82, Örebro, Sweden.
  15. School of Medical Sciences, University of Örebro, SE-701 82, Örebro, Sweden.
  16. IRiSC - Inflammatory Response and Infection Susceptibility Centre, Faculty of Medicine and Health, Örebro University, SE-701 82, Örebro, Sweden; Department of Clinical Research Laboratory, Faculty of Medicine and Health, Örebro University, SE-701 82, Örebro, Sweden.
  17. Department of Pharmaceutical Sciences, University of Milan, 20133 Milano, and IRIB, C.N.R, 90146, Palermo, Italy.
  18. Department of Medical Biochemistry and Biophysics, Karolinska Institute, SE-171 77, Stockholm, Sweden.
  19. Brigham and Women's Hospital, Department of Medicine, Pulmonary and Critical Care Medicine and Harvard Medical School, Boston, MA, 02115, USA.
  20. Department of Pathology and Cell Biology, University of Montreal, Research Center, Maisonneuve-Rosemont Hospital, Montreal, QC, H1T 2M4, Canada.
  21. Department of Systems Biology and Bioinformatics, University of Rostock, 18051, Rostock, Germany; Stellenbosch Institute for Advanced Study (STIAS), Wallenberg Research Centre at Stellenbosch University, Stellenbosch, South Africa. Electronic address: [email protected].

PMID: 32873427 DOI: 10.1016/j.mam.2020.100893

[No abstract available.]

Publication Types

Grant support